Details for New Drug Application (NDA): 206556
✉ Email this page to a colleague
The generic ingredient in BUPROPION HYDROCHLORIDE is bupropion hydrochloride. There are thirty-eight drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride profile page.
Summary for 206556
Tradename: | BUPROPION HYDROCHLORIDE |
Applicant: | Invagen Pharms |
Ingredient: | bupropion hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206556
Mechanism of Action | Dopamine Uptake Inhibitors Norepinephrine Uptake Inhibitors |
Physiological Effect | Increased Dopamine Activity Increased Norepinephrine Activity |
Suppliers and Packaging for NDA: 206556
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 206556 | ANDA | Preferred Pharmaceuticals Inc. | 68788-8537 | 68788-8537-1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-1) |
BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 206556 | ANDA | Preferred Pharmaceuticals Inc. | 68788-8537 | 68788-8537-3 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-3) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 150MG | ||||
Approval Date: | Aug 26, 2016 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Aug 26, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription